Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhage

NeuroReport

Volumn 21, Issue 13, 2010, Pages 892-896

  Luo, Chunxia ^a   Yi, Bin ^a   Tao, Guocai ^a   Li, Mei ^a   Chen, Zhi ^a   Tang, Weihua ^a   Zhang, John H ^b   Feng, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adenosine A3 receptor agonist; early brain injury; inflammatory cytokines; microglia; subarachnoid haemorrhage

Indexed keywords

2 CHLORO N6 (3 IODOBENZYL) ADENOSINE 5' N METHYLURONAMIDE; ADENOSINE A3 RECEPTOR; CYTOKINE; INTERLEUKIN 1BETA; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; CELL ACTIVATION; CONTROLLED STUDY; INFLAMMATION; MALE; MICROGLIA; MORTALITY; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBARACHNOID HEMORRHAGE;

ADENOSINE; ADENOSINE A3 RECEPTOR AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN INJURIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 77955912447     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32833dbd13     Document Type: Article

References (22)

1. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006; 26:1341-1353.
2. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa Set al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31:151-158.
3. Gao C, Liu XZ, Shi HZ, Xu SC, Ji ZY,Wang CLet al. Relationship between sympathetic nervous activity and inflammatory response after subarachnoid hemorrhage in a perforating canine model. Auton Neurosci 2009; 147:70-74.
4. Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa Set al. Role of interleukin-1b in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009; 40:2519-2525.
5. Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko Let al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009; 29:317-330.
6. Chen GJ, Harvey BK, Shen H, Chou J, Victor A, Wang Y. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 2006; 84:1848-1855.
7. Roseti C, Martinello K, Fucile S, Piccari V, Mascia A, Di Gennaro Get al. Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors. Proc Natl Acad Sci 2008; 105:15118-15123.
8. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinasedependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 2004; 65:1462-1474.
9. Van der Putten C, Zuiderwijk-Sick EA, van Straalen L, de Geus ED, Boven LA, Kondova Iet al. Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. J Immunol 2009; 182:7603-7612.
10. Ochaion A, Bar-Yehuda S, Cohen S, Barer F, Patoka R, Amital Het al. The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol 2009; 258:115-122.
11. Morschl E, Molina JG, Volmer JB, Mohsenin A, Pero RS, Hong JSet al. A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 2008; 39:697-705.
12. Lee JY, Jhun BS, Oh YT, Lee JH, Choe W, Baik HHet al. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-a production through inhibition of PI-3-kinase/Akt and NF-kB activation in murine BV2 microglial cells. Neurosci Lett 2006; 396:1-6.
13. Hammarberg C, Schulte G, Fredholm BB. Evidence for functional adenosine A3 receptors in microglia cells. J Neurochem 2003; 86:1051-1054.
14. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24:916-925.
15. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 2008; 167:327-334.
16. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26:627-634.
17. Hanafy KA, Morgan Stuart R, Fernandez L, Schmidt JM, Claassen J, Lee Ket al. Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage. J Clin Neurosci 2010; 17:22-25.
18. Iseda K, Ono S, Onoda K, Satoh M, Manabe H, Nishiguchi Met al. Antivasospastic and anti-inflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg 2007; 107:128-135.
19. Dengler J, Schefold JC, Graetz D, Meisel C, Splettstö sser G, Volk HDet al. Point-of-care testing for interleukin-6 in cerebro spinal fluid (CSF) after subarachnoid haemorrhage. Med Sci Monit 2008; 14:BR265-BR268.
20. Hailer NP. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 2008; 84:211-233.
21. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 2005; 56:1082-1092.
22. Haskó G, Pacher P, Vizi ES, Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 2005; 26:511-516.